DePuy Synthes se separa de Johnson & Johnson

Más como este

• Salud23/09/2026@HealthDesk

  J&J Announces Plan to Spin Off DePuy Synthes

  Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson·…

  

  Empieza el 14/10/2025CONFIRMADO90% DE CONFIANZAhace 344 díasThe release is datelined "NEW BRUNSWICK, NJ, October 14, 2025 - Johnson & Johnson ... today announced the Company's intent to separate its Orthopaedics business"; it states no time of day (CNBC's^[3] report was up at 6:29 a.m. EDT and J&J's X post at 6:40 a.m. EDT), so the pin is the all-day 14 October.

  Johnson & Johnson said it would separate its roughly $9.2 billion-a-year orthopaedics business into a standalone company called DePuy Synthes within 18 to 24 months, and named former Smith & Nephew chief Namal Nawana to run it.

  0.81

  00
• Empresas23/09/2026@HealthDesk

  Apollo in Talks to Buy J&J's DePuy Synthes for About $20 Billion

  Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson·…

  

  Empieza el 11/09/2026CONFIRMADO82% DE CONFIANZAhace 12 díasThe disclosure is Bloomberg's report, dated "September 11, 2026" (Yahoo's^[1][2][5] syndicated copy went up at 22:26 UTC and quotes Friday's closing share prices); Reuters' write-up the same evening says "Bloomberg News reported on Friday", and Quartz's 14 September story is a follow-up, so the pin is the all-day 11 September.

  Bloomberg reported that Apollo Global Management is in talks to buy DePuy Synthes, J&J's $9.3 billion-a-year orthopaedics unit, at a value close to $20 billion, with a deal possible within weeks though J&J could still spin the unit off instead.

  $20B

  0.73

  00
• Empresas23/09/2026@HealthDesk

  J&J Completes Its $1 Billion Acquisition of Firefly Bio

  South San Francisco, San Mateo County, California, United StatesJohnson & Johnson·…

  

  Empieza el 29/07/2026CONFIRMADO87% DE CONFIANZAhace 56 días"NEW BRUNSWICK, NJ (July 29, 2026) - Johnson & Johnson (NYSE: JNJ^[1][3]) today announced the successful completion of its acquisition of Firefly Bio, Inc. ... for $1 billion in cash"; the 8-K furnishing it gives "Date of report (Date of earliest event reported): July 29, 2026".

  Johnson & Johnson closed its $1 billion cash purchase of Firefly Bio, the South San Francisco biotech behind the Firelink degrader antibody conjugate platform for KRAS-driven and other hard-to-treat solid tumours.

  $1B

  0.65

  00
• Salud23/09/2026@HealthDesk

  J&J Picks Wilson, North Carolina for a Second 500-Job Drug Plant

  Wilson, Wilson County, North Carolina, United StatesJohnson & Johnson·…

  

  Empieza el 09/01/2026CONFIRMADO87% DE CONFIANZAhace 257 díasThe governor's release is dated "Friday, January 9, 2026" and begins "Today Governor Josh Stein announced Johnson & Johnson ... will expand its presence in North Carolina"; the Wilson Times^[3] says Stein "made the announcement Friday afternoon".

  North Carolina Governor Josh Stein announced that Johnson & Johnson will build a second multibillion-dollar plant in Wilson, a drug product manufacturing facility for cancer and neurology medicines expected to create up to 500 jobs, beside the $2 billion biologics campus it is already building there.

  0.65

  00
• Salud23/09/2026@HealthDesk

  J&J Signs a Drug-Pricing Deal With Trump and Joins TrumpRx

  Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson·…

  

  Empieza el 08/01/2026CONFIRMADO86% DE CONFIANZAhace 258 díasJ&J's release is datelined "New Brunswick, N.J. – JANUARY 8, 2026" and says the company "today announced a voluntary agreement with the Trump Administration"; coverage followed on 9 January.^[1]

  Johnson & Johnson signed a voluntary most-favored-nation drug-pricing agreement with the Trump administration, selling medicines through TrumpRx.gov and to Medicaid at prices comparable to other developed countries in exchange for an exemption from pharmaceutical tariffs, and announced two new US plants in Pennsylvania and North Carolina.

  0.62

  00
• Energía23/09/2026@EnergyDesk

  B&W and Denham Capital Partner to Repower Coal Plants for Data Centers

  Babcock & Wilcox·…1200, East Market Street, East End, Goodyear Heights, Akron, Summit County, Ohio, 44305, United States

  Empieza el 10/09/2025 10:30CONFIRMADO89% DE CONFIANZAel año pasadoStated as done, per B&W's release "(AKRON, Ohio – September 10, 2025)": "announced today the signing of a strategic partnership agreement with Denham Capital's^[4] Sustainable Infrastructure arm"; the Business Wire copy on Yahoo Finance is timestamped 2025-09-10T10:30:00Z (6:30 a.m. ET).

  Babcock & Wilcox and Denham Capital's Sustainable Infrastructure arm will jointly convert existing coal-fired plants, largely to natural gas, to power data centres in the US and Europe. B&W supplies the engineering and technology; Denham leads development and financing. No plant is named yet, so the pin sits at B&W's Akron headquarters.

  0.60

  00
• Derecho23/09/2026@HealthDesk

  J&J Proposes $5.5 Billion Deal to Settle 76,000 Ovarian Cancer Talc Claims

  Johnson & Johnson·…Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United States

  Empieza el 27/07/2026 22:15CONFIRMADO82% DE CONFIANZAhace 58 díasJ&J's release is datelined "New Brunswick, N.J. - JULY 27, 2026 - Johnson & Johnson (NYSE: JNJ^[1]) ... today announced", and the copy filed as Exhibit 99.1 to its 8-K is marked "FOR RELEASE AT 6:15PM ET", 22:15 UTC in EDT.

  Johnson & Johnson announced a proposed resolution of its remaining ovarian talc litigation, about 76,000 claims, with a $5.5 billion commitment paid per claim - no more than $3 billion in 2027 and nothing more before 2028 - if at least 95% of claimants take part.

  $5.5B

  0.60

  00
• Finanzas23/09/2026@HealthDesk

  J&J Third-Quarter 2026 Results and Investor Call

  Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson·…

  

  Empieza el 13/10/2026 12:30PROGRAMADO73% DE CONFIANZAdentro de 20 díasScheduled by J&J's 31 August release: it "will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 13th to review third-quarter results" and "The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call"; 8:30 a.m. EDT is 12:30 UTC.^[1]

  Johnson & Johnson releases its third-quarter 2026 results at about 6:45 a.m. Eastern on Tuesday 13 October and reviews them on an 8:30 a.m. investor call hosted by CEO Joaquin Duato and CFO Joseph Wolk.

  0.60

  00
• Energía23/09/2026@EnergyDesk

  B&W Gets Go-Ahead to Supply SolveBright Carbon Capture to a US Power Plant

  1200, East Market Street, East End, Goodyear Heights, Akron, Summit County, Ohio, 44305, United StatesBabcock & Wilcox·…

  

  Empieza el 08/12/2025 11:30CONFIRMADO82% DE CONFIANZAhace 289 díasStated as done, per B&W's release "(AKRON, Ohio – December 8, 2025)": "announced today that it has received limited notice to proceed"; the Business Wire copy on Yahoo Finance is timestamped 2025-12-08T11:30:00Z (6:30 a.m. ET).^[1]

  Babcock & Wilcox received a limited notice to proceed on engineering and long-lead purchasing for a SolveBright CO2-capture system at an unnamed existing US power plant, sized to capture more than 550,000 tons a year. The full contract, expected by March 2026, is worth an estimated $80 million; the plant is not named, so the pin sits at B&W's Akron headquarters.

  $80M

  0.59

  00
• Salud23/09/2026@HealthDesk

  FDA Authorizes Abbott's Libre Duo Glucose-Ketone Sensor

  Abbott Laboratories·…1360 South Loop Road, Alameda, Alameda County, California, 94502, United States

  Empieza el 25/08/2026CONFIRMADO87% DE CONFIANZAhace 29 díasThe release is datelined "ABBOTT PARK, Ill., Aug. 25, 2026" and says Abbott "today announced U.S. Food and Drug Administration (FDA^[2][3]) authorization of its Libre Duo 10 Day system"; the FDA's De Novo record gives the same decision date, 08/25/2026.

  The FDA authorized Abbott's Libre Duo 10 Day, the first wearable to continuously track both glucose and ketones, which alerts people with diabetes aged 2 and older to rising ketones before diabetic ketoacidosis.

  0.59

  00
• Finanzas23/09/2026@HealthDesk

  J&J Q2 2026 Results: $25.3B Sales, 2026 Outlook Raised

  Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson·…

  

  Empieza el 15/07/2026 12:30CONFIRMADO83% DE CONFIANZAhace 70 díasConfirmed by J&J's release dated "New Brunswick, N.J. (July 15, 2026)", which says it "will conduct a conference call with investors to discuss this earnings release today at 8:30 a.m., Eastern Time" (12:30 UTC; the edited transcript is stamped "JULY 15, 2026 / 12:30PM GMT").^[1]

  Johnson & Johnson reported second-quarter sales of $25.3 billion, up 6.6%, and adjusted EPS of $2.90, and raised its 2026 outlook to about $101.1 billion in sales and $11.68 adjusted EPS at the midpoint.

  0.58

  00
• Audio14/09/2026@GameDesk

  JBL Cove Series

  Stamford, Connecticut, USAJBL

  

  Empieza el 08/10/2026CONFIRMADO80% DE CONFIANZAdentro de 15 díasLa propia nota de prensa de JBL (https://news.jbl.com^[3]/en-CEU/269714-jbl-launches-jbl-cove-a-new-whole-home-audio-system-to-enjoy-superior-sound-throughout-the-entire-home/) anuncia la gama Cove el 1 de septiembre de 2026 e indica que los altavoces «se lanzan en blanco y negro en JBL.com^[1] a partir del 8 de octubre de 2026». Esa fecha de disponibilidad indicada por el fabricante se usa como fecha del pin.

  Tres altavoces inalámbricos multisala construidos sobre la plataforma propia de JBL.

  0.58

  00